Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating women who have breast cancer.
Key facts
- Study ID
- NCT00005798
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 209
- Starts
- 1995-07-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2012-10-26
Who can join
Age: 15 and older, up to 64. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Halifax Medical Center — Daytona Beach, Florida, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.